Erbitux (Cetuximab)
Complete patient guide for uses, dosage, side effects, and safety information
Quick Facts
What Is Erbitux Used For?
Erbitux contains cetuximab, a monoclonal antibody that specifically targets and blocks cancer cell growth signals. It works by attaching to epidermal growth factor receptors (EGFR) on cancer cells, preventing them from receiving growth signals that cause tumors to grow and spread.
Primary Uses
Erbitux is used to treat metastatic colorectal cancer (cancer of the colon or large intestine and rectum that has spread to other parts of the body), either alone or with chemotherapy. It's also used for locally advanced head and neck cancer in combination with radiation therapy, and for recurrent/metastatic head and neck cancer with certain chemotherapy medicines.
How It Works
Erbitux is a monoclonal antibody that blocks epidermal growth factor receptors (EGFR) on cancer cells. When growth factors attach to these receptors, they signal the cell to grow and divide. Many tumors have overactive EGFR receptors, leading to uncontrolled cancer growth. Erbitux attaches to these receptors more tightly than natural growth factors, blocking the growth signals and interfering with cancer cell growth.
Important: For colorectal cancer patients, your doctor will test your cancer cells to check if they have normal (wild-type) RAS genes. Erbitux only works for patients with normal RAS genes, not mutated ones.
Continue Reading
Sign in to access the complete medication guide including dosage, side effects, warnings, and more.
How to Take Erbitux
Erbitux is given as an intravenous infusion (slow injection into a vein) by trained medical professionals in a healthcare setting. You'll receive anti-allergy medicines at least 1 hour before each dose to prevent allergic reactions.
Dosage Instructions
Your doctor will calculate the correct dose based on your body surface area (height and weight). The first dose takes approximately 2 hours via infusion. Following doses are given weekly (1 hour infusion) or every 2 weeks (2 hours infusion). If receiving chemotherapy with Erbitux, the chemotherapy can only start 1 hour after the Erbitux infusion ends.
What If You Miss a Dose?
If you miss an appointment for your Erbitux infusion, call your healthcare provider immediately to reschedule. It's important to keep all appointments so your progress can be monitored.
Pre-medication Required: You must receive anti-allergy medicines (antihistamine and corticosteroid) at least 1 hour before each Erbitux dose to minimize allergic reaction risk.
Side Effects
Like all medications, this medicine can cause side effects. Most are mild and temporary, but some require medical attention.
Common Side Effects
These side effects occur relatively frequently and usually don’t require emergency care:
- Headache
- Red, watery eyes with pain and blurred vision
- Diarrhea and abdominal pain
- Nausea and vomiting
- Acne-like rash
- Itchy, dry, scaling skin
- Excessive hair growth
- Nail problems
- Weakness and fatigue
- Loss of appetite and weight loss
- Dehydration
- Sore, red, or dry mouth with possible nosebleeds
- Fever, chills, shortness of breath, dizziness during infusion
- Signs of frequent infections
- Chest pain or tightness
Seek immediate medical attention if you experience:
- Severe breathing difficulties with wheezing, hoarseness, hives
- Rapidly developing lumpy rash with chest or leg pain
- Severe blistering or peeling of skin (Stevens-Johnson syndrome)
- Worsening skin infections with fever and tiredness
- Sudden breathing difficulties with cough or fever (lung inflammation)
- Inflammation of brain lining (aseptic meningitis)
- Leg swelling or pain (blood clots)
- Blood clots in lungs
- Reduced white blood cell count leading to serious infections
- Heart attack or heart failure symptoms
- Hand-foot syndrome (redness and swelling of palms and soles)
Important Warnings
Erbitux has specific requirements and warnings that must be carefully followed for safe treatment.
Who Should Not Take Erbitux
Do not use Erbitux if you're allergic to cetuximab or any ingredients, if your cancer cells contain mutated RAS genes, if your RAS status is unknown (especially with oxaliplatin-containing treatments), or if you've had previous allergic reactions to red meat, tick bites, or α-1-galactose.
Medical Conditions to Discuss
Tell your doctor if you have abnormal blood test results, liver problems, kidney problems, heart problems (especially if 65+ years old), lung problems or breathing difficulties, acute or worsening eye problems, blurred vision, eye pain, red eyes, severe dry eyes, or if you use contact lenses.
Pregnancy and Breastfeeding
Erbitux is not recommended during pregnancy. Use adequate contraception during treatment and for 2 months after your last dose. Do not breastfeed during treatment and for 2 months after your last dose. The effectiveness in children under 18 has not been established.
Heart Problems: If you have heart problems and are 65 years or older, your doctor will carefully evaluate whether you can safely receive Erbitux with other anticancer medicines.
Drug Interactions
Some medicines may interfere with Erbitux and affect how it works. Always tell your doctor about all medicines you're taking.
Timing Important: If receiving chemotherapy with Erbitux, the chemotherapy can only be started 1 hour after the end of the Erbitux infusion.
- Chemotherapy medicines (timing is important – chemotherapy can only start 1 hour after Erbitux infusion)
- Radiation therapy (your doctor will discuss benefits and risks)
- Any prescription medicines
- Over-the-counter medicines
- Vitamins and supplements
Alcohol & Driving
Treatment-related symptoms can affect your concentration and ability to react, so caution is needed with activities requiring alertness.
Alcohol
No specific alcohol warnings mentioned in the source material. Discuss alcohol use with your doctor.
Driving and Operating Machinery
Be careful before driving or using machines until you know how Erbitux affects you. Treatment-related symptoms can affect your concentration and ability to react.
Storage
Erbitux is stored and handled by healthcare professionals in medical facilities. It comes as a clear to slightly cloudy, colorless to yellowish solution in glass vials that are kept under proper medical storage conditions.
Overdose Information
Since Erbitux is given under medical supervision, overdose is very unlikely. However, if you think you've received too much, immediately call the Poisons Information Centre at 13 11 26, contact your doctor, or go to the nearest hospital Emergency Department, even if you feel fine.
Frequently Asked Questions
Your doctor will determine how long you'll receive Erbitux based on your response to the medicine and the type of cancer you have. Progress is monitored through regular appointments and blood tests.
You should limit sun exposure and wear protective clothing, a hat, and SPF 30+ sunscreen when going outside. Sun exposure can make skin reactions worse.
Skin reactions like acne-like rash, itchy or dry skin are common and usually develop within the first three weeks. Your doctor may prescribe antibiotics or topical steroid cream to help prevent or minimize these reactions.
You'll be closely monitored during each infusion and for at least 1 hour afterwards. Your doctor will conduct blood tests before starting treatment and periodically during treatment to check how the medicine is working.
Erbitux is not recommended during pregnancy. You must use adequate contraception during treatment and for 2 months after your last dose. Contact your doctor immediately if you become pregnant during treatment.
You'll receive anti-allergy medicines before each dose to prevent reactions. If you experience severe breathing difficulties, wheezing, hives, or rapidly developing rash during or after infusion, seek immediate medical attention.
For colorectal cancer, your doctor will test your cancer cells to check if they have normal (wild-type) RAS genes. Erbitux only works for patients whose cancer cells express normal RAS genes, not mutated ones.
Important Disclaimer
This information is intended for general educational purposes only and should not be considered medical advice. Always consult your healthcare provider or pharmacist before starting, stopping, or changing any medication.
If you think you may have a medical emergency, call your doctor or emergency services immediately.